183 results on '"Nishimoto, Koshiro"'
Search Results
2. Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project
3. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation
4. Test–retest repeatability of quantitative bone SPECT/CT
5. FRI166 Characterization of Aldosterone-producing Cell Cluster (APCC) At Single-cell Resolution
6. Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions
7. Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study from experienced institutes
8. Pathology and gene mutations of aldosterone-producing lesions
9. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
10. Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone
11. Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
12. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution
13. O9-1 Updated analysis of circulating tumor DNA in advanced genitourinary cancers: SCRUM-Japan MONSTAR SCREEN Project
14. Lower neutrophil‐to‐lymphocyte ratio and positive programmed cell death ligand‐1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma
15. Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long‐term treatment‐free survival with pembrolizumab and axitinib in the KEYNOTE‐426 phase III trial of pembrolizumab and axitinib versus sunitinib
16. Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells
17. Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study
18. Adrenocortical Carcinoma Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration
19. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism
20. Bone Morphogenetic Protein-4 (BMP4): A Paracrine Regulator of Human Adrenal C19 Steroid Synthesis
21. PS3-2 Genomic characterization of circulating tumor DNA in advanced genitourinary cancer patients SCRUM-Japan MONSTAR SCREEN
22. Sodium Deficiency Regulates Rat Adrenal Zona Glomerulosa Gene Expression
23. Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma
24. Histopathological Diagnosis of Primary Aldosteronism Using CYP11B2 Immunohistochemistry
25. Effect of KCNJ5 Mutations on Gene Expression in Aldosterone-Producing Adenomas and Adrenocortical Cells
26. Transcriptome Analysis Reveals Differentially Expressed Transcripts in Rat Adrenal Zona Glomerulosa and Zona Fasciculata
27. Editorial Comment to Local advanced adrenocortical cancer with a long‐term recurrence‐free survival treated with complete surgical excision and adjuvant therapy with a very low‐dose mitotane
28. A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapy
29. Extension of Survival in Bilaterally Adrenalectomized Mice by Implantation of SF-1/Ad4BP-Induced Steroidogenic Cells
30. Efficacy of Nivolumab Plus Ipilimumab in a Patient With Renal Cell Carcinoma Concomitant With Cardiac Metastasis: A Case Report
31. Adrenocortical Zonation in Humans under Normal and Pathological Conditions
32. Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study.
33. Supplemental Figure 2
34. Supplemental Figure 1 with legend.pdf
35. Supplemental Material and Methods
36. Supplemental Figure 3
37. Clinical Impact of Consolidative and Salvage Radiotherapy for Lymph Node Metastasis in Upper Urinary Tract Urothelial Carcinoma
38. 5-アミノレブリン酸を用いた診断への取り組み
39. Supplemental Figure 1.pdf
40. Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
41. A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis‐assisted transurethral resection involving orally administered 5‐aminolevulinic acid
42. Delayed nivolumab‐induced hepatotoxicity during pazopanib treatment for metastatic renal cell carcinoma: An autopsy case
43. TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease
44. Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma
45. Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
46. Ectopic adrenal adenoma causing gross hematuria: Steroidogenic enzyme profiling and literature review
47. Meningeal carcinomatosis from bladder cancer: A case report and review of the literature
48. Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib
49. Histological complete response with nivolumab for renal cell carcinoma with multiple metastases: A case report
50. Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.